163
Views
13
CrossRef citations to date
0
Altmetric
Articles

Correlates of Adherence Among Rural Indian Women Living With HIV/AIDS

, , , , , , , & show all
Pages 327-345 | Published online: 19 Nov 2012
 

Abstract

In this prospective, randomized clinical trial, correlates of adherence to antiretroviral therapy (ART) were assessed using a baseline questionnaire among 68 rural women living with AIDS (WLA) in India. Unadjusted analyses revealed positive relationships of ART adherence with Hindu religion and support from spouses and parents, whereas negative associations were found with depression, poor quality of life, and having 10 or more HIV symptoms. Multiple linear regression analysis also revealed that WLA who were Hindu, not depressed, had ART support from spouses and parents, and perceived some benefit from ART, were more adherent to ART than their respective counterparts. This study reveals the unique challenges which rural WLA experience and the need to mitigate these challenges early in ART treatment. Further, the findings enable the refinement of an intervention program that will focus on strengthening ART adherence among rural WLA.

Acknowledgments

Support for this research was provided by grant MH82662 from the National Institute on Mental Health.

Notes

a An average score of 3 or above was used to dichotomize as “poor quality of life.”.

a Average score was used in the analysis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.